Crolius Clayton, CFO of DNA X, Inc. ($SONM), made one open market sale of common shares in the last year, totaling $16,869 on April 23, 2025. This activity ranks 11,117th among 11,678 insiders in our database, well below the average of $8.6 million per seller across 6.4 transactions. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | DNA X, Inc. | $SONM | Crolius Clayton | Chief Financial Officer | A | Common Stock | 35000 | $0.00 | 36,719.0000 | 1,028,693 | 2036.07% | 3.40% |
| April 23, 2025 | DNA X, Inc. | $SONM | Crolius Clayton | Chief Financial Officer | S | Common Stock | 11634 | $1.45 | 30,958.0000 | 6,324,057 | 27.31% | 0.18% |
| Feb. 6, 2025 | DNA X, Inc. | $SONM | Crolius Clayton | Chief Financial Officer | A | Common Stock | 33922 | $0.00 | 42,592.0000 | 0 | 391.26% | 0.00% |
| April 8, 2024 | DNA X, Inc. | $SONM | Crolius Clayton | Chief Financial Officer | A | Employee Stock Option (Right-to-Buy) | 170000 | $0.00 | 170,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 24, 2023 | DNA X, Inc. | $SONM | Crolius Clayton | Chief Financial Officer | A | Employee Stock Option (Right-to-Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 15, 2023 | DNA X, Inc. | $SONM | Crolius Clayton | Chief Financial Officer | P | Common Stock | 86700 | $0.68 | 86,700.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2023 | DNA X, Inc. | $SONM | Crolius Clayton | Chief Financial Officer | A | Employee Stock Option (Right-to-Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |